Americold Realty Trust (COLD)vsLineage, Inc. Common Stock (LINE)
COLD
Americold Realty Trust
$11.31
-0.18%
REAL ESTATE · Cap: $3.24B
LINE
Lineage, Inc. Common Stock
$34.89
-1.30%
REAL ESTATE · Cap: $8.81B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 106% more annual revenue ($5.36B vs $2.60B). LINE leads profitability with a -1.9% profit margin vs -4.4%. COLD earns a higher WallStSmart Score of 37/100 (F).
COLD
Hold37
out of 100
Grade: F
LINE
Hold36
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
ROE of -3.7% — below average capital efficiency
Revenue declined 120.0%
Earnings declined 66.7%
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : COLD
The strongest argument for COLD centers on Price/Book.
Bull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bear Case : COLD
The primary concerns for COLD are PEG Ratio, Return on Equity, Revenue Growth.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Key Dynamics to Monitor
LINE is growing revenue faster at -0.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
COLD scores higher overall (37/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Americold Realty Trust
REAL ESTATE · REIT - INDUSTRIAL · USA
Americold is the world's largest publicly traded REIT, focusing on the ownership, operation, acquisition and development of temperature controlled warehouses.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company at the forefront of regenerative medicine, specializing in the development of advanced cell therapy solutions aimed at treating severe diseases such as eye disorders, spinal cord injuries, and cancer. Leveraging proprietary technologies and a strong commitment to strategic partnerships, the company is dedicated to revolutionizing patient care with its novel therapeutic approaches. As Lineage continues to enhance its diverse product pipeline and accelerate clinical research initiatives, it represents a compelling opportunity for institutional investors looking to support transformative advancements in healthcare.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?